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Abstract
Background: Intravenous access in critically ill and injured patients can be difficult or impossible in the field.
Intraosseous access is a well-established alternative to achieve access to a noncollapsible vascular network. We
wanted to compare the use of a sternal and tibial/humeral intraosseous device in a physician-staffed helicopter
emergency medical service.
Methods: The helicopter emergency medical service in Bergen, Norway, is equipped with two different
intraosseous devices, the EZ-IO and FAST-Responder. We compared insertion time, insertion sites, flow, indication
for intraosseous access, and complications between the tibial/humeral and sternal techniques.
Results: In 49 patients, 53 intraosseous insertions were made. The overall intraosseous rate was 1.5% (53 insertions
in 3600 patients treated). The main patient categories were cardiac arrest and trauma. Overall, 93.9% of the
insertions were successful on the first attempt. The median insertion time using EZ-IO was 15 s compared to 20 s
using FAST-Responder. Insertion complications registered using the EZ-IO included extravasation, aspiration failure
and insertion time > 30 s. Using FAST-Responder, there were reported complications such as user failure (12.5%) and
insertion time > 30 s (12.5%). Regarding the flow, we found that 35.1% of the EZ-IO insertions experienced poor
flow and needed a pressure bag. With FAST-Responder, the flow was reported as very good or good in 85.7%, and
no insertions had poor flow.
Conclusion: Intraosseous access seems to be a reliable rescue technique in our helicopter emergency medical
service, with high insertion success rates. EZ-IO was a more rapid method in gaining vascular access compared to
FAST-Responder. However, FAST-Responder may be a better method when high-flow infusion is needed. Few
complications were registered with both techniques in our service.
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Background
The intraosseous (IO) method has been described as a
simple and reliable method to achieve vascular access in
both cadaver and clinical studies [1, 2]. Studies have
shown that IO can be a fast method with few complica-
tions, and the method gives access to a noncollapsible vas-
cular network in the intraosseous space [3–5]. However,
IO may be contraindicated if the patient has an infection
at the site of insertion, traumatic limb injuries or osseous
pathology [6, 7]. The IO route is a rapid, simple and safe
procedure in both pediatric and adult patients, with an
effectiveness equivalent to peripheral venous cannulation
in terms of pharmacokinetic and clinical efficacy [1, 4]. In
theory, any medication and virtually all types of fluids that
can be given intravenously can be infused via an IO
access. It has been suggested that hypertonic or
strongly alkaline agents should be avoided or diluted
as they have been associated with increased incidence
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of complications [5, 8, 9]. However, we have found
that all resuscitation drugs can be delivered through a
verified IO access [1, 7].
In our physician-staffed helicopter emergency medical
service (HEMS), IO is mainly used as a rescue technique
when primary attempts at establishing intravenous
access fail [3]. We have previously compared several IO
methods (Bone Injection Gun, EZ-IO and Inter V man-
ual bone marrow aspiration needle), and we found that
EZ-IO was the most successful method [3]. However, a
sternal route was not available during the previous study
period. Today, the HEMS is equipped with two types of
intraosseous devices: EZ-IO and FAST-Responder
(FAST-R). The EZ-IO, a battery powered device, is most
commonly used in the proximal and distal tibia, as well
as in the humeral head. The FAST-R is a semiautomatic
device intended for sternal insertion only. In pediatric
patients, the proximal tibia is a well-established site for
IO insertion; however, the optimal insertion site for
adults is often debated [2]. Regarding IO in pediatric
patients, EZ-IO seems to be the better option and is
a reliable method in prehospital conditions in all ages
[3, 8, 10]. Currently, there are no available FAST-R
options for pediatric patients.
Only a few studies have compared sternal to tibial/hu-
meral IO in critically ill patients in a prehospital setting
[11, 12]. There is still limited research on sternal IO
access, and many studies have been on cadaver models
[11]. It has been shown that the FAST-1, the predecessor
to FAST-R, has high flow rates [11]. Our objective was
to evaluate the use of EZ-IO and FAST-R regarding
insertion time and sites, flow, indication for IO and
complications in prehospital emergencies.
Methods
Study aim
Our primary objectives were to evaluate the insertion
times, insertion sites, complications and flow rates in
two different intraosseous devices used by our HEMS.
The secondary objectives were to describe IO insertion
criteria and main patient categories.
Study design and setting
The study was designed as a quality assurance study in
our HEMS based at Haukeland University Hospital,
Bergen, Norway. This service is operational 24/7 and is a
physician-staffed service. Seven prehospital anesthesiolo-
gists and 10 flight paramedics performed the IO
insertions and collected the data prospectively. All
patients requiring IO from January 1st, 2014 to Novem-
ber 30th, 2016 were included in the study. There were
no exclusion criteria.
Materials
Our HEMS is equipped with two different IO devices:
EZ-IO (® Vidacare Corp, San Antonio, Texas) and FAST-
Responder (® Pyng Medical Corporation, Vancouver, BC,
Canada). EZ-IO is a battery powered device enabling 500–
1000 insertions [13]. EZ-IO has three different needle
sizes (the smallest is certified down to 3 kg) [14]. It is most
commonly used in three different insertion sites
(proximal and distal tibia and the humeral head). In
1997, FAST-1 was the first FDA approved sternal IO
system. In 2013, PYNG launched FAST-R, a modified
version of FAST-1, to meet the needs of civilian
emergency medical services and hospital critical care
personnel. FAST-R is a disposable semiautomatic de-
vice for sternal insertion only, in which the insertion
site is located just below the sternal notch. It cannot
be used in children < 12 years of age [15]. Only one
attempt can be made per FAST- unit, whereas mul-
tiple attempts are possible using the EZ-IO [12].
Data
The data was analyzed for insertion time, flow, indica-
tion for IO, insertion site and complications. IO device
placement was confirmed by loss of resistance, aspir-
ation of bone marrow or blood, and/or administration of
saline and fluid administration. Insertion time was
recorded in seconds from placement against skin until
vascular access was confirmed by aspiration of bone
marrow or infusion of fluids. Flow was evaluated based
on drip chamber flow and categorized as very good
(continuous flow without pressure bag), good (fast drip
without pressure bag), adequate (slow drip without pres-
sure bag) or poor (poor flow and in need of pressure
bag). All primary and final insertion sites were recorded.
The physicians recorded insertion related complications
such as technical issues, extravasation, IO needle detach-
ment, failed aspiration, fracture when inserting, insertion
time exceeding 30 s and difficulty in localizing insertion
site. Patient journals were checked for all patients admit-
ted to the hospital for late complications, such as osteo-
myelitis, fracture after IO insertion or compartment
syndrome. In case of missing data, the attending prehos-
pital physician was contacted to provide supplemental
data.
Statistics
SPSS statistics (software version 23.0,® SPSS Inc.,
Chicago, USA) was used for statistical calculations. The
Mann-Whitney U-test was conducted to compare inser-
tion time between EZ-IO and FAST-R. A difference in
insertion time was considered significant if the p-value
was < 0.05.
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Results
During the study period, 53 insertions were made in 49
patients, and 69.3% of patients were male. This group in-
cluded 10.2% pediatric patients < 18 years. The total IO
rate was 1.5% (53 insertions in 3600 patients treated).
Main patient categories are mentioned in Fig. 1.
Insertion success
A total of 93.9% of the insertions were successful on
the first attempt. The remaining 6.1% of the inser-
tions were successful on the second attempt. The
median insertion time using the EZ-IO was shorter
compared to FAST-R: 15 s and 20 s, respectively. A
significant difference in insertion times was found
when we included the outliers (Fig. 2). A comparison
of flow is illustrated in Fig. 3.
Complications
Insertion complications when using EZ-IO included
extravasation (2.4%), aspiration failure (11.9%) and inser-
tion time > 30 s (4.8%). Using FAST-R, complications
were reported such as user failure (12.5%) and insertion
time > 30s (12.5%). It was reported that 8% of the
patients experienced pain during infusion. A total of
34.7% of the patients survived until hospital admittance,
and 20.4% were alive after 30 days. No cases of
long-term insertion complications were described in the
in-hospital journals at discharge (or death).
Insertion criteria
IO was used as a bridge to later IV in 32%. In 28%, the
IO insertion was used because of failed IV access. In
15%, patients received IO parallel to IV attempts. All IO
insertions were made on critically ill or injured patients.
Insertion sites
The main EZ-IO insertion site was in the proximal tibia
(90.5%); however, 9.5% of the EZ-IO were inserted in the
humerus. All FAST-R insertions were sternal (100%).
With EZ-IO, 2.4% of the tibial insertions failed, and an-
other successful attempt was made in the humeral head.
Of the patients receiving FAST-R, 25% of the insertions
were reported as failures. These patients subsequently
received successful tibial insertions using the EZ-IO.
IO administrations
In most cases, the patient needed medications (77.6%)
and/or fluids (55.1%). Plasma or whole-blood was
administered in 10.2% of cases. In 6.1% of the patients,
nothing was administered through the IO.
Discussion
Main results
To our knowledge, this is the first study comparing
FAST-R and EZ-IO. In general, we experienced a low
complication rate using both IO techniques. Our study
showed a high insertion success rate on the first attempt,
and all insertions were successful after two attempts.
Although the EZ-IO may be a faster technique, our
Fig. 1 The percentage of the patient categories receiving IO insertion
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study suggests that the FAST-R may have a place when
high-flow infusion rates in patients are required.
Calkins et al. described two failures in 31 attempts
with sternal placement using FAST-1 caused by lack
of continuous increasing pressure over the sternal
insertion site [12]. Regarding the FAST-R insertion
failures in our study, the patients subsequently
received successful IO insertions with the EZ-IO. This
finding may indicate that some training with the
devices is recommended.
Fig. 2 Intraosseous insertion times for EZ-IO and FAST-R, including the identified outliers
Fig. 3 Flow was evaluated based on drip chamber flow and categorized as very good (continuous flow without pressure bag), good (fast drip
without pressure bag), adequate (slow drip without pressure bag) or poor (poor flow and in need of pressure bag)
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Using the EZ-IO, extravasation occurred in 2.3% of
the patients, and aspiration failure was experienced in
11.9% of the cases. In 2.3% of the patients receiving
EZ-IO insertions, low battery caused an insertion time >
30s. Compared to FAST-R, this result shows that EZ-IO
has an expected shelf-life, which is estimated by the manu-
facturer to be approximately 10 years or 500 insertions.
However, aspiration failure was regarded as a complication
and occurred using both IO methods. This issue could
result in physicians attempting another IO insertion, even
though the previous IO might have been correctly inserted
in the intramedullary space [13, 16]. Hammer et al. also
showed that both methods are easy to use, even by medical
students without any specific training [11]. In a prehospital
environment, the physician tends to choose the method he
or she is familiar with since IO is mainly used as a rescue
technique. Our HEMS has good experience using the
EZ-IO, which could explain the low number of FAST-R
insertions.
We found a significant difference in insertion
times, as we could not exclude the outliers from
the data. However, given our low number of
FAST-R insertions, the outliers have a huge impact
on the analysis. In a study conducted by Hammer
et al., no significant difference in insertion times or
in first pass insertion success rates were found
between EZ-IO and FAST-R [11]. This result might
indicate that a higher number of FAST-R insertions
could have improved our insertion times since we
observed a minimal difference in median insertion
times. Nonetheless, comparing studies may be diffi-
cult due to different patient populations and study
protocols [17].
We found that none of the FAST-R infusions needed a
pressure bag to maintain a very good flow. None of the
EZ-IO insertions experienced very good flow, and 33.3%
needed a pressure bag. Pasley et al. concluded that the
sternal IO provided a more consistent and higher flow
rates compared to tibial or humeral insertions [2].
Our results also showed a larger number of EZ-IO
insertions in the proximal tibia compared to the hu-
merus, which was also the case in a previous study con-
ducted in our HEMS. This site may be preferred in
different HEMSs in Norway and other European coun-
tries due to an easy detectable landmark, and it has the
advantage of not interfering with ongoing cardiopulmo-
nary resuscitation (CPR), parallel IV insertion or assisted
ventilation [3]. With FAST-R, the only option is sternal
insertion. This site may not always be easily accessible,
as it is close to the compression site during CPR. A
blunt trauma to the sternum may also prevent FAST-
placement [12]. This factor may explain why our physi-
cians or flight paramedics may prefer EZ-IO for primary
insertion.
Almost all medications and fluids, as well as blood
components, can also be administered through a IO
access [11]. Our findings support this approach, as our
patients received necessary drugs, crystalloids, plasma or
whole blood. In 3 patients, the IO remained unused.
This finding may indicate that a certain overuse in this
patient group will be inevitable.
We found a higher number of IO insertions during
our study period compared to an earlier study in our
service [3]. Increased use of IO may indicate that the
threshold for using IO has decreased following increased
user experience with IO in our service or that improved
devices are available. All the insertions were made by
trained physicians and paramedics with experience in
establishing IV access. Compared to the study conducted
by Sunde et al., we recorded a lower number of IO inser-
tions in pediatric emergencies [3]. This difference may
indicate that our crews have improved their skills in
establishing IV access in younger patients. In our HEMS,
IO is primarily used as a rescue technique if other
attempts at vascular access fails, and the technique
needs to be reliable. The use of IO is generally recom-
mended as a rescue technique in critically ill or injured
patients if intravenous access cannot be achieved. In
situations in which the patients suffer from severe hypo-
volemic/hemorrhagic shock, IV access is difficult or
impossible, and our operational, prehospital conditions
make this issue even more challenging. Thus, research is
essential to determine which device is the most efficient in
a prehospital service [3]. Additional clinical studies com-
paring intraosseous devices and insertion sites in the pre-
hospital environment are needed. New IO methods may
require more research to determine the best IO device.
Limitations of the study
A limitation in our study is the limited number of IO
insertions, especially using the FAST-R method. Add-
itionally, the evaluation on flow rate is based on the
physician’s assessment, with no objective volume
measurements. A randomized controlled study would be
difficult to conduct, as FAST-R cannot be randomly
inserted in all patients, excluding pediatric patients.
Strengths
Our study has been performed prospectively in a
prehospital setting, involving all the different factors one
has to consider when establishing an intraosseous
infusion in critically ill patients. The insertions were all
made by the same HEMS crews with the same training
and medical background, which we believe reduces the
interpretation bias. This approach has given a picture of
the functionality and efficiency of the method used, as
well as complications that might not be reported in a
controlled research environment.
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Conclusions
Intraosseous access has been shown to be a reliable res-
cue technique in our HEMS with high first-pass success
rates. EZ-IO seems to be a more rapid method to gain
vascular access compared to FAST-R. However, FAST-R
might be a better choice when high-flow infusions in
adults are indicated. Few complications were registered
with both devices.
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